MX2016004209A - Terapia con celulas de placenta humana y celulas hematopoyeticas. - Google Patents

Terapia con celulas de placenta humana y celulas hematopoyeticas.

Info

Publication number
MX2016004209A
MX2016004209A MX2016004209A MX2016004209A MX2016004209A MX 2016004209 A MX2016004209 A MX 2016004209A MX 2016004209 A MX2016004209 A MX 2016004209A MX 2016004209 A MX2016004209 A MX 2016004209A MX 2016004209 A MX2016004209 A MX 2016004209A
Authority
MX
Mexico
Prior art keywords
cells
therapy
human placenta
hematopoietic
hematopoietic cells
Prior art date
Application number
MX2016004209A
Other languages
English (en)
Spanish (es)
Inventor
Jodi P Gurney
Xiaokui Zhang
Stacy Herb
Robert J Hariri
Original Assignee
Anthrogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anthrogenesis Corp filed Critical Anthrogenesis Corp
Publication of MX2016004209A publication Critical patent/MX2016004209A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2016004209A 2013-10-03 2014-10-02 Terapia con celulas de placenta humana y celulas hematopoyeticas. MX2016004209A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361886648P 2013-10-03 2013-10-03
US201361890057P 2013-10-11 2013-10-11
PCT/US2014/058774 WO2015051088A1 (en) 2013-10-03 2014-10-02 Therapy with cells from human placenta and hematopoietic cells

Publications (1)

Publication Number Publication Date
MX2016004209A true MX2016004209A (es) 2016-07-11

Family

ID=52779130

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016004209A MX2016004209A (es) 2013-10-03 2014-10-02 Terapia con celulas de placenta humana y celulas hematopoyeticas.
MX2021003798A MX2021003798A (es) 2013-10-03 2016-04-01 Terapia con celulas de placenta humana y celulas hematopoyeticas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021003798A MX2021003798A (es) 2013-10-03 2016-04-01 Terapia con celulas de placenta humana y celulas hematopoyeticas.

Country Status (12)

Country Link
US (1) US10179152B2 (enExample)
EP (1) EP3052109B8 (enExample)
JP (4) JP2016531889A (enExample)
KR (3) KR20160102965A (enExample)
CN (1) CN105792834A (enExample)
AU (3) AU2014329513A1 (enExample)
CA (1) CA2926199C (enExample)
DK (1) DK3052109T3 (enExample)
MX (2) MX2016004209A (enExample)
RU (2) RU2016116816A (enExample)
WO (1) WO2015051088A1 (enExample)
ZA (1) ZA201602151B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437994A (en) * 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
WO2002064755A2 (en) * 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
BRPI0407427A (pt) * 2003-02-13 2006-01-24 Anthrogenesis Corp Método para tratar um paciente e para tratar a mielodisplasia
WO2007079184A2 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
EP1987135A2 (en) * 2006-01-27 2008-11-05 Auxocell Laboratories, Inc. Methods and compositions relating to stem cell transplantation
JP5260499B2 (ja) * 2006-05-11 2013-08-14 コード ブラッド サイエンス インコーポレイテッド 臍帯血幹細胞の回収方法及び使用方法
US8263065B2 (en) * 2007-09-28 2012-09-11 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells

Also Published As

Publication number Publication date
RU2016116816A (ru) 2017-11-13
KR20220044384A (ko) 2022-04-07
EP3052109B8 (en) 2021-06-23
AU2022215207A1 (en) 2022-09-01
KR20210054046A (ko) 2021-05-12
RU2019131152A3 (enExample) 2022-02-24
MX2021003798A (es) 2021-05-27
NZ718571A (en) 2023-12-22
KR20160102965A (ko) 2016-08-31
AU2014329513A1 (en) 2016-04-28
EP3052109B1 (en) 2021-05-12
JP2023078156A (ja) 2023-06-06
JP2021107407A (ja) 2021-07-29
RU2019131152A (ru) 2019-11-11
WO2015051088A1 (en) 2015-04-09
US20160235790A1 (en) 2016-08-18
CA2926199C (en) 2022-05-17
DK3052109T3 (da) 2021-08-16
CN105792834A (zh) 2016-07-20
ZA201602151B (en) 2022-12-21
JP2016531889A (ja) 2016-10-13
CA2926199A1 (en) 2015-04-09
US10179152B2 (en) 2019-01-15
JP2019194211A (ja) 2019-11-07
EP3052109A1 (en) 2016-08-10
AU2020202076A1 (en) 2020-04-09
RU2016116816A3 (enExample) 2018-08-02
EP3052109A4 (en) 2017-05-03

Similar Documents

Publication Publication Date Title
MX2025009223A (es) Agentes de union a clec9a y su uso
WO2015009726A3 (en) Medical uses of cd38 agonists
NZ707477A (en) Activin-actrii antagonists and uses for treating bone and other disorders
UA107814C2 (uk) Спірооксіндольні антагоністи мdм2
MX2015013355A (es) Terapia que involucra anticuerpos contra claudina 18.2 para el tratamiento de cancer.
MX2020011415A (es) Metodos de usar zscan4 para rejuvenecer celulas humanas.
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
ZA201804696B (en) Therapeutic use of inhibitors of t cell activation or stimulation
EA201491334A1 (ru) Композиции и способы для лечения метаболических расстройств
PH12018502593A1 (en) Combinations of linagliptin and metformin
MX388278B (es) Composiciones y metodos para inhibir masp-1 y/o masp-2 y/ o masp-3 para el tratamiento de la hemoglobinuria paroxistica nocturna
EP4124346A3 (en) Compositions and methods for treating diseases
MX2015016100A (es) Inhibidores de criopirina para prevenir y tratar la inflamacion.
MX2016009306A (es) Reequilibrado inmunologico epicutaneo.
PH12018500762A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
AU2018253575A1 (en) Natural killer cells from placenta
EA201790563A8 (ru) Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой
BR112015010039A2 (pt) tratamento de câncer com pomalidomida em um individuo com disfunção renal
EA201591522A1 (ru) Лечение реакции трансплантат против хозяина у подвергаемых трансплантации пациентов
MX2019000677A (es) Células miméticas de células b.
MX2021003798A (es) Terapia con celulas de placenta humana y celulas hematopoyeticas.
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
WO2015120436A3 (en) Stat3 phosphorylation during graft-versus-host disease
MX2021003799A (es) Composiciones que comprenden celulas perfundidas de placenta humana, subpoblaciones de las mismas y sus usos.
MX2019013207A (es) Metodos y composiciones para tratar la endometriosis y sintomas asociados a la endometriosis.